The Trump administration has ordered the National Institutes of Health to terminate dozens of studies examining why people are hesitant about vaccines and issues related to the LGBTQ community. The ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Investing News Network on MSN7h
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
It has been five years since the world was blown into the tumult of a lethal pandemic. Back then, deserted streets and ...
Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...
The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
For 2025, BioNTech management anticipates revenue between 1.7 billion euros and 2.2 billion euros, with planned R&D outlays reaching between 2.6 billion euros and 2.8 billion euros. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback